Skip to main content
. 2022 Nov 29;13:1004259. doi: 10.3389/fphar.2022.1004259

TABLE 3.

Results (MD, 95% CI) of Network Meta-Analysis for CD8+ (Upper Rightsection) and CD4+ (Lower Left section).

ADI + XELOX 9.09 (6, 12.21) 10.99 (8.16, 13.86) 1.24 (-0.58, 3.06) -0.5 (-2.9, 1.9) -3.8 (-5.7, -1.91) 3.04 (1.02, 5.04) 5.4 (3.79, 7)
-3.24 (-9.32, 2.84) BJOI + XELOX 1.9 (-1.66, 5.46) -7.85 (-10.66, -5.06) -9.6 (-12.81, -6.4) -12.9 (-15.75, -10.05) -6.06 (-8.99, -3.14) -3.7 (-6.37, -1.04)
-2.51 (-4.93, -0.08) 0.73 (-5.71, 7.18) CI + XELOX -9.75 (-12.26, -7.25) -11.49 (-14.47, -8.55) -14.8 (-17.37, -12.24) -7.96 (-10.59, -5.31) -5.6 (-7.96, -3.25)
-1.4 (-2.99, 0.18) 1.85 (-4.33, 8.01) 1.11 (-1.55, 3.75) CKSI + XELOX -1.74 (-3.73, 0.25) -5.05 (-6.36, -3.71) 1.8 (0.32, 3.29) 4.16 (3.28, 5.03)
-3 (-5.17, -0.84) 0.25 (-6.12, 6.58) -0.5 (-3.52, 2.54) -1.61 (-4.02, 0.81) MI + XELOX -3.3 (-5.34, -1.25) 3.54 (1.39, 5.7) 5.9 (4.11, 7.68)
-4.52 (-7.31, -1.72) -1.26 (-7.88, 5.3) -2.01 (-5.5, 1.49) -3.12 (-6.11, -0.13) -1.51 (-4.84, 1.83) SMYI + XELOX 6.84 (5.28, 8.41) 9.2 (8.19, 10.2)
-5.29 (-6.78, -3.79) -2.04 (-8.18, 4.1) -2.78 (-5.36, -0.18) -3.89 (-5.71, -2.04) -2.28 (-4.63, 0.07) -0.77 (-3.71, 2.17) SQFZI + XELOX 2.36 (1.15, 3.56)
3.79 (2.96, 4.62) 7.03 (1, 13.06) 6.3 (4.03, 8.57) 5.19 (3.83, 6.54) 6.79 (4.79, 8.79) 8.31 (5.64, 10.97) 9.08 (7.84, 10.31) XELOX

The values in bold are values with statistical analysis significance.